The U.S. Food and Drug Administration announced hiring more than 1,000 staffers to bolster review capacity and launched a pilot communications program letting sponsors send one 'quick clarification' email after meetings, promising responses within three business days. FDA Commissioner Marty Makary framed the moves as efforts to reduce review uncertainty and avoid months of sponsor guesswork. The initiatives follow workforce changes, missed deadlines and political scrutiny, and aim to improve throughput for drug reviews. Industry reaction was mixed: developers welcomed faster touchpoints but noted staffing alone may not resolve deeper procedural and scientific review challenges.